Michelle Dalton, ELS

Study evaluates the impact of surgical procedure on visual outcomes in patients

Understanding the per-person cost differences with 3 key management strategies for a better-informed treatment selection

How this method of anesthesia may provide benefits to both the patient and physician

Following trends by geographic variation in practice patterns, perceptions toward opioids, and patient population

Modifier-25 same-day examinations are critical to the successful treatment and overall health and well being of these patients.

Measuring high-quality care cannot be a barrier to providing it, notes John T. Thompson, MD.

Results could provide a new preferred treatment paradigm for this population

The application of sub-silicone oil TA crystals over relaxing retinectomy sites is a viable option in patients with complex RD with extreme PVR.

Subretinal transplantation of human embryonic stem cells (hESC)-derived retinal pigment epithelial (RPE) cells in patients with AMD and geographic atrophy (GA) appears well tolerated, according to date presented during ARVO 2020.

The number of patients with retinal diseases is steadily increasing in the United States, according to a retrospective study presented during ARVO 2020.

Patents gained less vision in clinical practice than patients on clinical trials

Reductions in macular retinal nonperfusion after anti-VEGF treatment with aflibercept are correlated with improvements in BCVA and central retinal thickness in patients with DR/DME, according to a post-hoc analysis of the VISTA dataset, said Charles C. Wykoff, MD, PhD, during ARVO 2020.

Early detection and anti-VEGF treatment of choroidal neovascularization (CNV) in the second eye leads to better mean final visual acuity (VA) with fewer injections at 1 year.